Nova Mentis (NOVA.C) is on a mission to incorporate psychedelics in treating chronic inflammatory conditions like autism spectrum disorder (ASD), fragile X syndrome (FXS), epilepsy, traumatic brain injury, multiple…
Taylor Gavinchuk
Sexy ass CPG products The psychedelics space is filled with outdated healthcare style branding reminiscent of hospital waiting rooms. It’s also filled with wildly futuristic Matrix bullshit. NeonMind Biosciences…
DMT biz dev Entheon Biomedical (ENBI.C) is going all-in on the DMT (dimethyltryptamine) game. They are the only DMT-focused company targeting addiction. The company is pre-revenue with phase 1…
Dead on arrival The European super league died before it even got started, putting 12 of Europe’s top teams in an incredibly awkward situation. All six of England’s breakaway…
Street cred MindMed (MMED.NEO) announced last fall it was applying to be listed on the Nasdaq Exchange. MindMed would be the first Canadian psychedelics company listed on a major…
“I want you to arrange a meeting, with the heads of the five families” – Don Corleone, The Godfather Boiling point News broke yesterday that football (soccer), the world’s…
$13 million give or take Earlier this week the law firms of Wolf Haldenstein Adler Freeman & Herz and The Portnoy Law Firm both announced class-action lawsuits against psychedelics…
Cedar Clinical Research Novamind (NM.C) announced today it’s increasing its investment in the Australian-based drug company Bionomics (BNO.ASX). The company is focused primarily on anxiety, PTSD, and central nervous…
It’s 2031, COVID is long gone. Jose Conseco is president of the USA. Jeff Bezos redesigns the human digestive system to not need food or water Peter Thiel spends…
Valens (VLNS.T), the Kelowna-based cannabis company has built one of the most legitimate businesses in the Canadian cannabis space. In Valen’s early stages the company was mainly focused on…